WM
W Todd Myers
CFO

W Todd Myers insider trades: Sgx Pharmaceuticals (SGXP) stock sales

CFO, Sgx Pharmaceuticals Last trade Aug 5, 2008 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
21
Open-market trades
since 2006
1
Company
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where W reports to the SEC

Open-market buys and sales

21 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 5, 2008SGXP↓ Sell$2K
Jul 7, 2008SGXP↓ Sell$1K
Jun 5, 2008SGXP↓ Sell$1K
May 5, 2008SGXP↓ Sell$1K
Apr 7, 2008SGXP↓ Sell$1K
Mar 5, 2008SGXP↓ Sell$3K
Feb 5, 2008SGXP↓ Sell$3K
Jan 7, 2008SGXP↓ Sell$4K
Dec 5, 2007SGXP↓ Sell$4K
Nov 5, 2007SGXP↓ Sell$5K
Oct 5, 2007SGXP↓ Sell$5K
Sep 5, 2007SGXP↓ Sell$5K
Aug 6, 2007SGXP↓ Sell$5K
Jul 5, 2007SGXP↓ Sell$4K
Jun 5, 2007SGXP↓ Sell$4K
May 7, 2007SGXP↓ Sell$4K
Apr 5, 2007SGXP↓ Sell$4K
Mar 5, 2007SGXP↓ Sell$4K
Feb 5, 2007SGXP↓ Sell$3K
Jan 5, 2007SGXP↓ Sell$3K
Dec 5, 2006SGXP↓ Sell$28K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About W Todd Myers's insider trades

W Todd Myers is CFO at Sgx Pharmaceuticals (SGXP). Since Dec 5, 2006, W has reported no open-market purchases and 21 sales worth $94K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (21 filings), grants and awards (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.